Bernhard C. Pestalozzi
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 19
- HER2/EGFR in Cancer Research 18
- Colorectal Cancer Treatments and Studies 16
- Cancer Treatment and Pharmacology 13
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Cancer Research top 2%
- Breast Cancer Treatment Studies 9
- Otorhinolaryngology top 2%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Pierre–Alain ClavienAchim WeberAron GoldhirschStefan HeinrichMonica Castiglione‐GertschThomas F. HanyRichard D. GelberRichard Herrmann
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Nature Communications (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (13 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Bernhard C. Pestalozzi
106 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 124
- Oncology 2.9k
- Hepatology 555
- Cancer Research 992
- Pulmonary and Respiratory Medicine 1.7k
- Otorhinolaryngology 203
Countries citing papers authored by Bernhard C. Pestalozzi
This map shows the geographic impact of Bernhard C. Pestalozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard C. Pestalozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard C. Pestalozzi more than expected).
Fields of papers citing papers by Bernhard C. Pestalozzi
This network shows the impact of papers produced by Bernhard C. Pestalozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard C. Pestalozzi. The network helps show where Bernhard C. Pestalozzi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernhard C. Pestalozzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2022 | 12 | |
| 3 | 2019 | 7 | |
| 4 | 2019 | 13 | |
| 5 | 2018 | 6 | |
| 6 | 2017 | 10 | |
| 7 | 2016 | 2 | |
| 8 | 2016 | 14 | |
| 9 | 2014 | 37 | |
| 10 | 2014 | 15 | |
| 11 | 2013 | 142 | |
| 12 | 2013 | 27 | |
| 13 | 2012 | 112 | |
| 14 | 2011 | 15 | |
| 15 | 2011 | 26 | |
| 16 | 2010 | 55 | |
| 17 | 2009 | 56 | |
| 18 | 2008 | 56 | |
| 19 | 2007 | 38 | |
| 20 | 2005 | 43 |
About Bernhard C. Pestalozzi
Bernhard C. Pestalozzi is a scholar working on Oncology, Hepatology and Cancer Research, having authored 107 papers that have together received 4.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), HER2/EGFR in Cancer Research (18 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Breast Cancer Treatment Studies (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Neuroendocrine Tumor Research Advances (8 papers). The work is most often cited by research in Oncology (2.9k citations), Hepatology (555 citations) and Cancer Research (992 citations). Bernhard C. Pestalozzi has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Pierre–Alain Clavien, Achim Weber, Aron Goldhirsch, Stefan Heinrich, Monica Castiglione‐Gertsch, Thomas F. Hany, Richard D. Gelber, Richard Herrmann, Alan S. Coates and Jurij Lindtner. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.